| [1] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
| [2] |
XU Tao, ZHU Suyan, QIU Xiangjun, XU Ping.
Population pharmacokinetics of teicoplanin in patients with renal insufficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 977-983.
|
| [3] |
WEN Dusu, WANG Yi, SUN Jianjun.
Comparison of Bayesian method and multiple linear regression method in predicting warfarin dose model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 33-38.
|
| [4] |
JIAO Zheng, LI Xingang, SHANG Dewei, DONG Jing, ZUO Xiaocong, CHEN Bing, LIU Jianmin, PAN Yan, ZHOU Tianyan, ZHANG Jing, LIU Dongyang, LI Lujin, FANG Yi, MA Guangli, DING Junjie, ZHAO Wei, CHEN Rui, XIANG Xiaoqiang, WANG Yuzhu, GAO Jianjun, XIE Haitang, HU Pei, ZHENG Qingshan.
Model informed precision dosing: China expert consensus report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1215-1228.
|
| [5] |
LIU Jianhui, ZHOU Genhong, LI Chunlin, BAO Meihua, LIU Fangyi.
Identification of myelodysplastic syndromes related long noncoding RNA by bioinformatics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1351-1356.
|
| [6] |
CHEN Chao, ZHENG Qingshan, LI Lujin, LI Xue, XU Ling.
Comparison of the calculation approaches of AUC in non-compartment model pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1381-1387.
|
| [7] |
LI Lujin, DING Junjie, LIU Dongyang, WANG Xipei, DENG Chenhui, JI Shangmin, CHEN Wenjun, MA Guangli, WANG Kun, SHENG Yucheng, XU Ling, PEI Qi, CHEN Yuancheng, CHEN Rui, SHI Jun, LI Gailing, WANG Yaning, WANG Yuzhu, XIE Haitang, ZHOU Tianyan, FANG Yi, ZHANG Jing, JIAO Zheng, HU Bei, ZHENG Qingshan.
General considerations of model-based meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1250-1267.
|
| [8] |
GAO Jingshu, WANG Yu, QIN Huichao, ZHU Mengyi, WU Xiaoke.
Strategy on improving quality of study of triazavirin for 2019 novel coronary pneumonia (COVID-19) with features of "core data targeted"
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1171-1177.
|
| [9] |
ZHONG Zihang, CHEN Feng, YUAN Ying, CHENG Jiancheng, YU Xuanxuan, YANG Min, TAN Mingmin, ZHAO Yang, BAI Jianling, YU Hao.
A novel model-assisted design in phase I clinical trials: Bayesian optimal interval design
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 640-648.
|
| [10] |
XU Xiaoyan, LIU Yuxiu.
Checkpoint checklist for ADaM submission package and SAS Macros for package validation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1388-1393.
|
| [11] |
WANG Yafei, CHEN Feng, BAI Jianling, HUANG Lihong, YU Hao.
Statistical performance comparison of different simultaneous global development designs for targeted drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1127-1132.
|
| [12] |
JIANG Cheng, LI Fangqiong, YE Zuowu, SUN Yunfeng, ZHANG Meiling, LI Gonghua .
Correlation analysis between the detection rate of CR-KP and the utilization of antibacterial drugs based on PLSR algorithm
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 904-909.
|
| [13] |
CHEN Mengkai, BAI Jianling, WEI Yongyue, HUANG Lihong, ZHAO Yang, YU Hao.
Effect of difference censored rates between groups in clinical trails
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 434-438.
|
| [14] |
CHEN Jiaren, CUI Yudi, TIAN Hao, WANG Hao.
Vortioxetine for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 52-59.
|
| [15] |
WU Yan, WU Cui-fang, WANG Jiang-lin.
Efficacy and safety of lixisenatide in comparison to placebo: a meta-analysis of randomized controlled trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 167-174.
|
